Since this does not have result directly in changed portal pressure, we can only reduce bleeding in 45% of patients 29% in non-treated vs. 14% in treated with evident risk factors 10.
De allí que solo se consiga una disminución del sangrado en un 45% de los pacientes 29% en tratados vs. 14% en no tratados con factores de riesgo evidentes 10.